Treatment of Acid-related Diseases Using Potassium-competitive Acid Blockers
Proton pump inhibitors (PPIs) have several limitations to their efficacy including insufficient acid suppression, slow onset of action, and variable efficacy among patients due to CYP2C19 metabolism. Potassium-competitive acid blockers inhibit H+-K+-ATPase in a reversible and K+-competitive manner,...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Jin Publishing & Printing Co.
2022-12-01
|
Series: | The Korean Journal of Gastroenterology |
Subjects: | |
Online Access: | https://www.kjg.or.kr/journal/view.html?uid=5874&vmd=Full |